John Northcott

Insider Reports History

Entity
Individual
Location
455 Mission Bay Boulevard South, C/O Nektar Therapeutics, San Francisco, CA
Signature
Mark A. Wilson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Northcott:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEKTAR THERAPEUTICS SVP & Chief Commercial Officer Common Stock 223K $109K $0.49 May 16, 2022 Direct
NEKTAR THERAPEUTICS SVP & Chief Commercial Officer Stock Option 67.2K Dec 16, 2021 Direct

Insider Reports Filed by John Northcott

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NKTR NEKTAR THERAPEUTICS May 16, 2022 1 -$18.1K 4 May 17, 2022 SVP & Chief Commercial Officer
NKTR NEKTAR THERAPEUTICS Feb 16, 2022 1 -$53.1K 4 Feb 18, 2022 SVP & Chief Commercial Officer
NKTR NEKTAR THERAPEUTICS Dec 16, 2021 2 $0 4 Dec 20, 2021 SVP & Chief Commercial Officer
NKTR NEKTAR THERAPEUTICS Nov 16, 2021 1 -$79.8K 4 Nov 17, 2021 SVP & Chief Commercial Officer
NKTR NEKTAR THERAPEUTICS Aug 16, 2021 1 -$85.6K 4 Aug 18, 2021 SVP & Chief Commercial Officer
NKTR NEKTAR THERAPEUTICS May 17, 2021 1 -$111K 4 May 19, 2021 SVP & Chief Commercial Officer